How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

An AI-powered crossword generator that models word placement as a constraint satisfaction problem (CSP). Given a grid pattern and a vocabulary, it finds a complete assignment of words while respecting ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Platforms used: GeeksforGeeks, LeetCode, takeUforward (TUF) only. Theory items (I/O, loops, STL, etc.) have no problem links. In a section, if a platform has no suitable basic problem, its column is ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. 1 tax payment and 1 sale were reported, with the sale representing $78,822.38 of the total.

At close: October 29 at 4:00:00 p.m. EDT ...